Ændringerne i MPAGs (MPAs phenoliske glucuronid) farmakokinetik (MPAG steg med 8%) var minimale og anses ikke for klinisk signifikante.
The changes in MPAG (the phenolic glucuronide of MPA) pharmacokinetics (MPAG increased by 8%) were minimal and are not considered clinically significant.